OPCH SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Option Care Health for Possible Securities Law Violations

Option Care Health guided investors to $5.8B-$6.0B in FY 2026 revenue on February 24, 2026. Sixty-five days later, the Company cut that figure by up to $175 million at the midpoint -- and the stock fell approximately 26.4%.